{"id":"W4409493832","doi":"10.1182/bloodadvances.2024015719","title":"Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovation Cluster (Canada)","funders":"MorphoSys; Swedish Orphan Biovitrum; Incyte; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Bispecific antibody; Refractory (planetary science); Lymphoma; Antibody therapy; Medicine; Antibody; CAR T-cell therapy; Cancer research; Oncology; Internal medicine; Immunology; T cell; Chimeric antigen receptor; Biology; Monoclonal antibody; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006596536,0.0002136275,0.0004520081,0.0002478727,0.0002297101,0.0005276219,0.0002097373,0.000450096,0.0007132707],"category_scores_gemma":[0.001184296,0.0001038542,0.0004547815,0.000280086,0.000213611,0.0002794114,0.0002994513,0.0004170767,0.0002457537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004246841,"about_ca_system_score_gemma":0.0001993015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006295054,"about_ca_topic_score_gemma":0.0005020359,"domain_scores_codex":[0.9996656,0.0001320672,0.00003493869,0.00005245848,0.00003903882,0.00007585959],"domain_scores_gemma":[0.9991546,0.0001855341,0.0003281373,0.00005114378,0.00004627321,0.0002344101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0262591,0.001141052,0.9177153,0.0001416883,0.0005180378,0.003798368,0.0003437806,0.001930168,0.01024979,0.0000978469,0.0005550091,0.03724992],"study_design_scores_gemma":[0.000664393,0.01779624,0.9695757,0.00003314901,0.0003875647,0.005236344,0.0001563305,0.002002318,0.002677842,0.0001191511,0.001328759,0.00002213115],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988954,0.0005905426,0.00009878774,0.00002548394,0.000004315862,0.00001263344,0.0001250386,0.000005426801,0.0002423059],"genre_scores_gemma":[0.9995703,0.00006506709,0.0000257121,0.0000248848,0.000007756925,0.000007243693,0.0002387639,0.000001377274,0.00005888938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007132707,"threshold_uncertainty_score":0.00348866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009952427921185381,"score_gpt":0.3055829094655686,"score_spread":0.2956304815443832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}